איקסמפרה 15 מ"ג

País: Israel

Idioma: hebreo

Fuente: Ministry of Health

Ingredientes activos:

IXABEPILONE 15 MG

Disponible desde:

BRISTOL-MYERS SQUIBB (ISRAEL) LIMITED

Código ATC:

L01DC04

formulario farmacéutico:

POWDER FOR CONCENTRATE FOR INFUSION

Vía de administración:

I.V

Fabricado por:

CORDEN PHARMA LATINA S.P.A., ITALY

Grupo terapéutico:

IXABEPILONE

indicaciones terapéuticas:

Ixempra is indicated for the treatment of inoperable locally advanced or metastatic breast cancer after failure of cytotoxic chemotherapy:In combination with capecitabine in patients failing prior therapy with a taxane and an anthracycline or for whom further anthracycline therapy is not indicated.As monotherapy in patients failing prior therapy with taxanes, capecitabine and anthracyclines or for whom futher anthracycline therapy is not indicated.

Fecha de autorización:

2012-01-01